Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Primo Chemicals
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 147.80 | 109.88 | 93.20 | 91.43 | 102.48 | 121.93 | 134.36 | 143.85 | 155.42 | 141.94 | 134.74 | 140.14 | 144.86 |
| Expenses + | 119.21 | 102.83 | 97.55 | 88.64 | 101.05 | 106.82 | 123.76 | 125.20 | 131.44 | 121.55 | 119.44 | 126.56 | 125.84 |
| Operating Profit | 28.59 | 7.05 | -4.35 | 2.79 | 1.43 | 15.11 | 10.60 | 18.65 | 23.98 | 20.39 | 15.30 | 13.58 | 19.02 |
| OPM % | 19.34% | 6.42% | -4.67% | 3.05% | 1.40% | 12.39% | 7.89% | 12.96% | 15.43% | 14.37% | 11.36% | 9.69% | 13.13% |
| Other Income + | 7.36 | 5.46 | 4.84 | 3.70 | 5.42 | 5.87 | 5.86 | 4.74 | 4.41 | 5.27 | 4.46 | 4.22 | 5.66 |
| Interest | 3.21 | 3.03 | 4.38 | 5.01 | 5.78 | 5.60 | 5.67 | 5.95 | 5.78 | 5.46 | 4.82 | 4.34 | 3.88 |
| Depreciation | 7.65 | 8.71 | 9.01 | 10.28 | 11.57 | 12.34 | 13.22 | 13.02 | 12.52 | 13.11 | 13.23 | 13.25 | 12.98 |
| Profit before tax | 25.09 | 0.77 | -12.90 | -8.80 | -10.50 | 3.04 | -2.43 | 4.42 | 10.09 | 7.09 | 1.71 | 0.21 | 7.82 |
| Tax % | 30.37% | 584.42% | 5.19% | 74.32% | -164.57% | 485.20% | -645.68% | 56.56% | 111.10% | 56.84% | -61.40% | 261.90% | 34.91% |
| Net Profit + | 17.60 | -4.29 | -12.94 | -15.19 | 7.09 | -11.25 | 12.93 | 2.29 | -0.41 | 4.08 | 4.16 | 1.05 | 6.07 |
| EPS in Rs | 0.73 | -0.18 | -0.53 | -0.63 | 0.29 | -0.46 | 0.53 | 0.09 | -0.02 | 0.17 | 0.17 | 0.04 | 0.25 |
Financials of Primo Chemicals
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 223 | 449 | 701 | 392 | 549 | 562 |
| Expenses + | 235 | 362 | 508 | 385 | 481 | 493 |
| Operating Profit | -12 | 87 | 192 | 7 | 68 | 68 |
| OPM % | -6% | 19% | 27% | 2% | 12% | 12% |
| Other Income + | 55 | 15 | 26 | 19 | 21 | 20 |
| Interest | 5 | 9 | 8 | 18 | 23 | 18 |
| Depreciation | 17 | 17 | 24 | 40 | 51 | 53 |
| Profit before tax | 20 | 76 | 186 | -31 | 15 | 17 |
| Tax % | 59% | 25% | 28% | -18% | 85% | 37% |
| Net Profit + | 8 | 59 | 137 | -25 | 4 | 15 |
| EPS in Rs | 0.53 | 2.44 | 5.67 | -1.05 | 0.15 | 0.63 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Primo Chemicals
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 31 | 48 | 48 | 48 | 48 | 48 |
| Reserves | 66 | 228 | 364 | 339 | 342 | 358 |
| Borrowings + | 1 | 61 | 145 | 178 | 169 | 131 |
| Other Liabilities + | 148 | 141 | 174 | 149 | 181 | 155 |
| Total Liabilities | 246 | 478 | 731 | 714 | 741 | 692 |
| Fixed Assets + | 156 | 155 | 278 | 468 | 497 | 469 |
| CWIP | 35 | 177 | 213 | 49 | 10 | 12 |
| Investments | 0 | 33 | 59 | 59 | 61 | 65 |
| Other Assets + | 55 | 114 | 181 | 138 | 173 | 145 |
| Total Assets | 246 | 478 | 731 | 714 | 741 | 692 |
Financials of Primo Chemicals
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 53 | 70 | 150 | 14 | 64 | 65 |
| Cash from Investing Activity + | -24 | -191 | -233 | -56 | -43 | -18 |
| Cash from Financing Activity + | -34 | 137 | 81 | 21 | -22 | -46 |
| Net Cash Flow | -5 | 16 | -3 | -21 | -0 | 1 |
| Free Cash Flow | 29 | -86 | -33 | -51 | 26 | 39 |
| CFO/OP | -421% | 97% | 95% | 397% | 94% | 97% |
Financials of Primo Chemicals
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 27 | 26 | 27 | 33 | 28 | 21 |
| Inventory Days | 52 | 84 | 47 | 106 | 104 | 34 |
| Days Payable | 231 | 216 | 112 | 147 | 195 | 34 |
| Cash Conversion Cycle | -152 | -106 | -38 | -8 | -63 | 20 |
| Working Capital Days | -160 | -47 | -31 | -89 | -67 | -58 |
| ROCE % | 39% | 43% | -2% | 7% | 6% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…